Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2026-01-03 @ 10:10 AM
Study NCT ID:
NCT04084769
Status:
COMPLETED
Last Update Posted:
2025-09-15
First Post:
2019-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Evaluate the Immune Response After a Booster Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine When Administered Alone or Concomitantly With a Licensed Meningococcal Serogroup B Vaccine, in Participants Who Received Primary Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
Sponsor:
Sanofi Pasteur, a Sanofi Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-03
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-09-14
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-04
First Submit QC Date:
None
Study First Post Date:
2019-09-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-08-03
Results First Submit QC Date:
None
Results First Post Date:
2021-08-30
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-11
Last Update Post Date:
2025-09-15
Last Update Post Date Type:
ESTIMATED